Elite Pharmaceuticals Inc

ELTP

Exchange: OTC
Industry: Pharmaceutical Preparations
SEC CIK: 0001053369

SEC filings (opens in a new tab)

In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Elite Pharmaceuticals Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of ELTP: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Q3 2021	Change
Holders	2	1	−1
Shares	248.8K	200.0K	−48.8K (−19.6%)
Value	$12.0K	$9.00K	−$3.00K (−25.0%)

New holders (0)

Institutions that held Elite Pharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.

None.

Sold out (1)

Institutions that held Elite Pharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of ELTP in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Captrust Financial Advisors	48,778	$2.00K